Thiamine (B1) and Thiamine (B1) for Diabetic neuropathy (benfotiamine)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Thiamine (B1)
Small stores, fast turnover — deficiency (beriberi, Wernicke's) is a medical emergency; routine supplementation rarely does more.
Grade B2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Thiamine (B1) for Diabetic neuropathy (benfotiamine)
Evidence grade B — Modest symptom relief
Grade B1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Thiamine (B1) | Thiamine (B1) for Diabetic neuropathy (benfotiamine) |
|---|---|---|
| Diabetic neuropathy (benfotiamine) | Evidence grade BSmall effectmixedModest symptom relief | Evidence grade BSmall effectmixedModest symptom relief |
Graded only in Thiamine (B1)
- Deficiency syndromes Large effectEvidence grade A
Graded only in Thiamine (B1) for Diabetic neuropathy (benfotiamine)
None — every outcome it grades is graded in both.
What each entry says about the other
- Thiamine (B1) for Diabetic neuropathy (benfotiamine)’s entry · Goes with: Read the full Thiamine (B1) monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.